awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38074121-39F435A2-1891-4472-9578-D7A4955E920D
Q38074121-39F435A2-1891-4472-9578-D7A4955E920D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074121-39F435A2-1891-4472-9578-D7A4955E920D
Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.
P2860
Q38074121-39F435A2-1891-4472-9578-D7A4955E920D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38074121-39F435A2-1891-4472-9578-D7A4955E920D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97e6971c90f641178518b456e65c533735b1ecf5
P2860
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.